Is Swet-Chem Antibiotics Ltd (531186) a good quality company?

Data is not available for this company.

What is Swet-Chem Antibiotics Ltd (531186) share price return in the past 10 years?

Data is not available for this company

What is the share price of Swet-Chem Antibiotics Ltd (531186)?

Company share prices are keep on changing according to the market conditions. The current trading price of Swet-Chem Antibiotics Ltd (531186) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Swet-Chem Antibiotics?

The latest standalone P/E ratio of Swet-Chem Antibiotics as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Swet-Chem Antibiotics Ltd (531186)?

The latest standalone P/B ratio of Swet-Chem Antibiotics Ltd (531186) as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Swet-Chem Antibiotics Ltd (531186)?

The 52-week high of Swet-Chem Antibiotics Ltd (531186) is Rs. 0.00 and the 52-week low is Rs. 0.00.

Swet-Chem Antibiotics Ltd (531186) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Swet-Chem Antibiotics Ltd (531186)
Brand: Swet-Chem Antibiotics

Swet-Chem Antibiotics Ltd (531186) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Swet-Chem Antibiotics Ltd (531186)

BSE: 531186 NSE:

Key Metrics

Market Cap

₹0 Cr.

P/E Ratio

0.00

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Return on Capital Employed (ROCE)

-0.39%

Current Price

₹0

Return on Equity (ROE)

-0.46%

Return on Assets (ROA)

-0.26%

Operating Profit Margin

Net Profit Margin

-INF%

Gross Profit Margin

Book Value per Share

₹10

Sales Growth (YoY)

NA%

Sales Growth (3 Years)

NA%

Operating Profit Growth (1 Year)

NA%

Operating Profit Growth (3 Years)

N/A%

Net Profit Growth (1 Year)

-100.55%

52-Week Low / High

₹0 / 0

Net Profit Growth (3 Years)

N/A%

Dividend Yield

0.00%

Promoter Holding

0.00%

Pledged shares (%)
of Promoter's holding (%)

0.00%

DeciZen - make an informed investing decision on Swet-Chem Antibiotics

Based on:

Data

M-Cap below 100cr DeciZen not available

Swet-Chem Antibiotics stock performance

Key Ratios

Is an attractive stock to invest in?

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	TTM
ROCE % ⓘ	0%	0%	0%	0%	0%	0%	0%	0%	101.4%	-0.4%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0	0	0	0	0	9.7	0	0	0
Sales YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	-100%	NA	-
Adj EPS ⓘ	0	0	0	0	0	0	-0.5	4.1	2.8	-0	-0
YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	-32.4%	-100.7%	-
BVPS (₹) ⓘ	0	0	0	0	0	0	0	0	4.6	4.6	10
Adj Net Profit ⓘ	0	0	0	0	0	0	-0.4	2.7	1.8	-0	-0
Cash Flow from Ops. ⓘ	0	0	0	0	0	0	0	0	4.3	-0	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	0	0.1	-142.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	NA	NA	NA
Adj EPS ⓘ	NA	NA	NA	-100.7%
BVPSⓘ	NA	NA	NA	-0.4%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'12	Mar'13	Mar'14	TTM
Return on Equity % ⓘ	0	119.7	-0.5	-0.3
Op. Profit Mgn % ⓘ	31.3	0	0	NAN
Net Profit Mgn % ⓘ	27.8	0	0	NAN
Debt to Equity ⓘ	0	0.2	0.2	-
Working Cap Days ⓘ	61	0	0	0
Cash Conv. Cycle ⓘ	178	0	0	0

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	-0	-
TTM Sales (₹ Cr.)	0	-
BVPS (₹) ⓘ	10	-
Reserves (₹ Cr.) ⓘ	-	-
P/BV ⓘ	0.00	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	1.50 / 7.00
Market Cap (₹ Cr.)	0
Equity (₹ Cr.)	0
Face Value (₹)	10
Industry PE ⓘ	44.8

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Swet-Chem Antibiotics - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14
Sales	0	9.68	0	0
Operating Expenses ⓘ +	0	6.65	0.01	0.01
Manufacturing Costs	0	0	0	0
Material Costs	0	6.64	0	0
Employee Cost	0	0	0	0
Other Costs ⓘ	0	0.02	0.01	0.01
Operating Profit ⓘ	-0	3.03	-0.01	-0.01
Operating Profit Margin (%)	-	31.3%	-	-
Other Income ⓘ +	0	0.01	1.86	0
Exceptional Items ⓘ	0	0	0	0
Interest ⓘ	0	0	0.03	0
Depreciation ⓘ	0.34	0.34	0	0
Profit Before Tax ⓘ	-0.35	2.69	1.82	-0.01
Tax ⓘ	0	0	0	0
Profit After Tax	-0.35	2.69	1.82	-0.01
PAT Margin (%)	-	27.8%	-	-
Adjusted EPS (₹)	0.0	0.0	2.8	-0.0
Dividend Payout Ratio (%)	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14
Equity and Liabilities
Shareholders Fund +	-3.95	-1.26	3.04	3.03
Share Capital ⓘ	6.60	6.60	6.60	6.60
Reserves ⓘ	-10.55	-7.86	-3.56	-3.57
Debt +	0	0	0.60	0.54
Long Term Debt	0	0	0.60	0.54
Short Term Debt	0	0	0	0
Minority Interest	0	0	0	0
Trade Payables	0	0	1.66	1.66
Others Liabilities ⓘ	3.95	1.26	0.07	0.08
Total Liabilities ⓘ	0	0	5.38	5.31
Fixed Assets
Net Fixed Assets ⓘ +	3.20	2.86	1.51	1.51
Gross Block	3.20	2.86	5.53	5.53
Accumulated Depreciation	0	0	4.03	4.03
CWIP ⓘ	0	0	0.42	0.42
Investments ⓘ	0	0	0	0
Inventories	6.64	0	0	0
Trade Receivables	1.40	1.40	1.40	1.40
Cash Equivalents	0	0	0.01	0.01
Others Assets ⓘ	-11.24	-4.26	2.04	1.98
Total Assets ⓘ	0	0	5.38	5.31

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'13	Mar'14
Cash Flow From Operating Activity ⓘ +	4.29	-0
PBT ⓘ	1.82	-0.01
Adjustment ⓘ	2.48	0
Changes in Working Capital ⓘ	-0.01	0.01
Tax Paid ⓘ	0	0
Cash Flow From Investing Activity ⓘ +	1.35	0
Capex	0	0
Net Investments	0	0
Others ⓘ	1.35	0
Cash Flow From Financing Activity ⓘ +	-5.64	0
Net Proceeds from Shares ⓘ	0	0
Net Proceeds from Borrowing ⓘ	0	0
Interest Paid ⓘ	0	0
Dividend Paid ⓘ	0	0
Others ⓘ	-5.64	0
Net Cash Flow ⓘ	0.01	-0

Finance Ratio

PARTICULARS	Mar'11	Mar'12	Mar'13	Mar'14
Ratios
ROE (%)	N/A	N/A	204.19	-0.46
ROCE (%)	N/A	N/A	101.43	-0.39
Asset Turnover Ratio	0	0	0	0
PAT to CFO Conversion(x)	N/A	-0	0	N/A
Working Capital Days
Receivable Days	0	52.80	0	0
Inventory Days	0	0	0	0
Payable Days	0	0	0	0

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Swet-Chem Antibiotics Ltd FAQs

The current trading price of Swet-Chem Antibiotics on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Swet-Chem Antibiotics stood at ₹0.00 Cr

The latest P/E ratio of Swet-Chem Antibiotics as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Swet-Chem Antibiotics as of 31-Dec-1969 is 0.00.

The 52-week high of Swet-Chem Antibiotics is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Swet-Chem Antibiotics is ₹0.00 ( Cr.) .

About Swet-Chem Antibiotics Ltd

No data to display

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Swet-Chem Antibiotics Ltd (531186) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating